Nektar TherapeuticsNKTRNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank57
3Y CAGR+66.6%
5Y CAGR+64.1%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+66.6%/yr
vs +25.7%/yr prior
5Y CAGR
+64.1%/yr
Consistent
Acceleration
+40.9pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
11.9x
Strong expansion
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.66 | -1.8% |
| 2024 | 1.69 | +87.8% |
| 2023 | 0.90 | +150.7% |
| 2022 | 0.36 | +70.2% |
| 2021 | 0.21 | +51.0% |
| 2020 | 0.14 | -52.0% |
| 2019 | 0.29 | +102.0% |
| 2018 | 0.14 | -94.9% |
| 2017 | 2.79 | -1.0% |
| 2016 | 2.82 | - |